Age-dependent and gender-specific changes in mouse tissue iron by strain

Experimental Gerontology

Volumn 44, Issue 9, 2009, Pages 594-600

  Hahn, Paul ^a   Song, Ying ^a   Ying, Gui shuang ^a   He, Xining ^a   Beard, John ^b   Dunaief, Joshua L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; Aging; Gender; Hemochromatosis; Iron; Mouse model; Neurodegenerative disease; Oxidative stress; Retinal degeneration; Strain

Indexed keywords

IRON;

ADULT ANIMAL; AGED; AGING; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRAIN; C57BL 6 MOUSE; CHOROID; CONTROLLED STUDY; DBA 2 MOUSE; FEMALE; GENETIC REGULATION; HEART; HORMONAL REGULATION; IRON METABOLISM; LIVER; MALE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; SEX DIFFERENCE; STRAIN DIFFERENCE; TISSUE DISTRIBUTION;

AGING; ANALYSIS OF VARIANCE; ANIMALS; FEMALE; IRON; MALE; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEX CHARACTERISTICS; SPECTROPHOTOMETRY; SUBCUTANEOUS TISSUE;

MUS;

EID: 68749103147     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.06.006     Document Type: Article

References (44)

1. Anderson M.G., Libby R.T., Mao M., Cosma I.M., Wilson L.A., Smith R.S., and John S.W. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol. 4 (2006) 20
2. Bartzokis G., Mintz J., Sultzer D., Marx P., Herzberg J.S., Phelan C.K., and Marder S.R. In vivo MR evaluation of age-related increases in brain iron. AJNR Am. J. Neuroradiol. 15 6 (1994) 1129-1138
3. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., Huang D., Edwards N., and Mintz J. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging. 28 3 (2007) 414-423
4. Chen, H., Liu, B., Lukas, T.J., Suyeoka, G., Wu, G., Neufeld, A.H., 2008. Changes in iron-regulatory proteins in the aged rodent neural retina. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2008.01.002.
5. Cook C.I., and Yu B.P. Iron accumulation in aging: modulation by dietary restriction. Mech. Ageing Dev. 102 1 (1998) 1-13
6. Cook J.D., Finch C.A., and Smith N.J. Evaluation of the iron status of a population. Blood 48 3 (1976) 449-455
7. Dallman P.R., Siimes M.A., and Stekel A. Iron deficiency in infancy and childhood. Am. J. Clin. Nutr. 33 1 (1980) 86-118
8. Dinneen S.F., O'Mahony M.S., O'Brien T., Cronin C.C., Murray D.M., and O'Sullivan D.J. Serum ferritin in newly diagnosed and poorly controlled diabetes mellitus. Ir. J. Med. Sci. 161 11 (1992) 636-638
9. Erikson K.M., Pinero D.J., Connor J.R., and Beard J.L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr. 127 10 (1997) 2030-2038
10. Farkas R.H., Chowers I., Hackam A.S., Kageyama M., Nickells R.W., Otteson D.C., Duh E.J., Wang C., Valenta D.F., Gunatilaka T.L., Pease M.E., Quigley H.A., and Zack D.J. Increased expression of iron-regulating genes in monkey and human glaucoma. Invest. Ophthalmol. Vis. Sci. 45 5 (2004) 1410-1417
11. Goodrick C.L. Life-span and the inheritance of longevity of inbred mice. J. Gerontol. 30 3 (1975) 257-263
12. Grundy M.A., Gorman N., Sinclair P.R., Chorney M.J., and Gerhard G.S. High-throughput non-heme iron assay for animal tissues. J. Biochem. Biophys. Methods 59 2 (2004) 195-200
13. Hadziahmetovic M., Dentchev T., Song Y., Haddad N., He X., Hahn P., Pratico D., Wen R., Harris Z.L., Lambris J.D., Beard J., and Dunaief J.L. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest. Ophthalmol. Vis. Sci. 49 6 (2008) 2728-2736
14. Hahn P., Milam A.H., and Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol. 121 8 (2003) 1099-1105
15. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris Z.L., and Dunaief J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 101 38 (2004) 13850-13855
16. Hahn P., Ying G.S., Beard J., and Dunaief J.L. Iron levels in human retina: sex difference and increase with age. Neuroreport 17 17 (2006) 1803-1806
17. Hallgren B., and Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3 1 (1958) 41-51
18. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 9 (2001) 685-716
19. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.Q., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R.A., Bush A.I., and Andersen J.K. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37 6 (2003) 899-909
20. Massie H.R., Aiello V.R., and Banziger V. Iron accumulation and lipid peroxidation in aging C57BL/6J mice. Exp. Gerontol. 18 4 (1983) 277-285
21. Massie H.R., Aiello V.R., and Williams T.R. Iron accumulation during development and ageing of Drosophila. Mech. Ageing Dev. 29 2 (1985) 215-220
22. Massie H.R., Aiello V.R., and Williams T.R. Inhibition of iron absorption prolongs the life span of Drosophila. Mech. Ageing Dev. 67 3 (1993) 227-237
23. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., Masters C.L., Li Q.X., and Bush A.I. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J. Inorg. Biochem. 100 5-6 (2006) 952-962
24. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., White A.R., Beyreuther K., Masters C.L., Bush A.I., and Li Q.X. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277 47 (2002) 44670-44676
25. Morita A., Kimura M., and Itokawa Y. The effect of aging on the mineral status of female mice. Biol. Trace Elem. Res. 42 2 (1994) 165-177
26. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., and David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22 15 (2002) 6578-6586
27. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., and Smith M.A. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16 5 (2002) 339-352
28. Polla A.S., Polla L.L., and Polla B.S. Iron as the malignant spirit in successful ageing. Ageing Res. Rev. 2 1 (2003) 25-37
29. Polla B.S. Therapy by taking away: the case of iron. Biochem. Pharmacol. 57 12 (1999) 1345-1349
30. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 3 (1992) 803-811
31. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94 18 (1997) 9866-9868
32. Staats J. Standardized nomenclature for inbred strains of mice: eighth listing. Cancer Res. 45 3 (1985) 945-977
33. Stevens R.G., Jones D.Y., Micozzi M.S., and Taylor P.R. Body iron stores and the risk of cancer. N. Engl. J. Med. 319 16 (1988) 1047-1052
34. Stuckey R., Aldridge T., Lim F.L., Moore D.J., Tinwell H., Doherty N., Davies R., Smith A.G., Kimber I., Ashby J., Orphanides G., and Moggs J.G. Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol. Cell. Endocrinol. 253 1-2 (2006) 22-29
35. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 8233 (1981) 1293-1294
36. Sullivan J.L. The iron paradigm of ischemic heart disease. Am. Heart J. 117 5 (1989) 1177-1188
37. Taylor B.A. Genetic relationships between inbred strains of mice. J. Hered. 63 2 (1972) 83-86
38. Torrance J.D., and Bothwell T.H. A simple technique for measuring storage iron concentrations in formalinised liver samples. S. Afr. J. Med. Sci. 33 1 (1968) 9-11
39. Unger E.L., Beard J.L., and Jones B.C. Iron regulation in C57BLI6 and DBA/2 mice subjected to iron overload. Nutr. Neurosci. 10 1-2 (2007) 89-95
40. Unger E.L., Earley C.J., and Beard J.L. Diurnal cycle influences peripheral and brain iron levels in mice. J. Appl. Physiol. 106 1 (2009) 187-193
41. Youdim M.B., Ben-Shachar D., and Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?. Acta Neurol. Scand. Suppl. 126 (1989) 47-54
42. Zacharski L.R., Chow B.K., Howes P.S., Shamayeva G., Baron J.A., Dalman R.L., Malenka D.J., Ozaki C.K., and Lavori P.W. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J. Natl. Cancer Inst. 100 14 (2008) 996-1002
43. Zacharski L.R., Ornstein D.L., Woloshin S., and Schwartz L.M. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am. Heart J. 140 1 (2000) 98-104
44. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 4 (1988) 1049-1060